Alternatives to ibandronate
2 same-class SPL records vs ibandronate - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Boniva
About ibandronate
Ibandronate (Boniva) is a medicine that helps treat and prevent bone loss in women after menopause. It makes bones stronger and less likely to break.
Used for: Ibandronate is used to treat and prevent osteoporosis in women after menopause. Osteoporosis is a condition that makes bones weak and more likely to break. This medicine helps to increase bone strength and reduce the chance of fractures, especially in the spine.
2 Bisphosphonate peers (wide set)
alendronate
RxFosamax
Binosto treats osteoporosis, a condition that weakens bones and makes them more likely to break. It helps to increase bone mass in both postmenopausal women and men who have osteoporosis. Using this medicine can lower your chance of having fractures, including hip and spine fractures. Talk to your doctor about how long you should take this medicine.
risedronate
RxActonel
This medicine treats osteoporosis in women after menopause. Osteoporosis makes bones weak and more likely to break. Risedronate can lower the chance of breaks in the spine and other bones.
ibandronate vs alendronate & risedronate · FAERS reaction fields
FAERS top-reaction field "Femur Fracture" shows the widest count spread between ibandronate and alendronate, risedronate in this extract (11,118-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | ibandronate | alendronate | risedronate |
|---|---|---|---|
| Arthralgia | 243 | 11,003 | 3,730 |
| Diarrhoea | 230 | - | 2,685 |
| Nausea | 219 | 7,565 | 2,991 |
| Femur Fracture | 216 | 11,334 | - |
| Headache | 198 | - | 2,327 |
| Fatigue | 190 | 12,775 | 2,911 |
| Fall | 165 | 8,164 | 1,987 |
| Dizziness | 163 | - | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
ibandronate peer mix vs class inventory
Peer mix
0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Bisphosphonate: 3 drugs.
Frequently Asked Questions
What same-class SPL records sit beside ibandronate? ▼
Reading a wide Bisphosphonate peer set (2 records)
ibandronate (Boniva) sits in a wide Bisphosphonate peer set (2 of 2 class peers shown). Labeled indication field for ibandronate: Ibandronate is used to treat and prevent osteoporosis in women after menopause.
Top FAERS reaction fields for ibandronate total 1,939 reports across 10 reactions, set beside alendronate, risedronate. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for ibandronate: see also the generic vs brand label guide when reading Boniva SPL strings.
Read our methodology - how this data is sourced, computed, and verified.